TD Cowen Downgrades Bio-Techne Corp. (TECH) to Hold
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/13/2026
- Nasdaq falls ahead of earnings, economic data while oil rallies
- Oil prices rise on Saudi Arabia attacks, overshadowing Trump's diesel deal
- Will surging equity supply derail the U.S. bull market? Goldman Sachs weighs in
- Broadcom CEO says many AI investors are gamblers
- "Not buying Chipotle": Starbucks squashes blockbuster acquisition speculation
Tweet
Share
E-mailGet Alerts TECH Hot Sheet
Price: $72.56 +0.14%
Rating Summary:
7 Buy, 15 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 19 | Down: 21 | New: 69
Rating Summary:
7 Buy, 15 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 19 | Down: 21 | New: 69
Join SI Premium – FREE
TD Cowen analyst Kyle Boucher downgraded Bio-Techne Corp. (NASDAQ: TECH) from Buy to Hold with a price target of $73.00.
For an analyst ratings summary and ratings history on Bio-Techne Corp. click here. For more ratings news on Bio-Techne Corp. click here.
Shares of Bio-Techne Corp. closed at $71.00 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UBS Downgrades Greggs Plc. (GRG:LN) (GGGSF) to Neutral
- Morgan Stanley Downgrades Arch Capital (ACGL) to Equalweight
- UBS Starts TechnipFMC (FTI) at Buy
Create E-mail Alert Related Categories
DowngradesRelated Entities
Cowen & Co, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
